Abstract
We examined the correlation among the levels of urinary monocyte chemoattractant protein‐1 (MCP‐1) and interleukin‐8 (IL‐8), hyperglycemia, and renal injuries in patients with type 2 diabetic nephropathy. The levels of urinary MCP‐1, IL‐8, protein excretion, blood urea nitrogen (BUN), serum creatinine (s‐Cr), glycohemoglobin A1c (HbA1c), and fasting plasma glucose (FPG) were measured in 24 patients with type 2 diabetic nephropathy and 14 healthy adults as controls. Diabetic nephropathy was classified into three stages: stage 1 = normoalbuminuric, stage 2 = microalbuminuric, and stage 3 = macroalbuminuric. All of the patients showed normal ranges in renal function tests. Levels of urinary MCP‐1 in all patients with diabetic nephropathy were significantly higher than those in healthy adults (P < 0.05). The levels of urinary MCP‐1 in patients with diabetic nephropathy increased gradually according to the clinical stage of this disease. In contrast, the levels of urinary IL‐8 in patients with diabetic nephropathy increased in stages 2 and 3. There was a significant correlation between the levels of urinary IL‐8 and those of HbA1c. High glucose may stimulate MCP‐1 and/or IL‐8 production and their excretion into the urine independently of the phases or pathological lesions of this disease. It appears that IL‐8 increased in the early stage of diabetic nephropathy, and MCP‐1 increased in the advanced stage of this disease. It was concluded that measurement of urinary MCP‐1 and IL‐8 may be useful for evaluating the degree of renal injuries in patients with type 2 diabetic nephropathy. J. Clin. Lab. Anal. 16:1–4, 2002. © 2002 Wiley‐Liss, Inc.
Keywords: urinary MCP‐1, IL‐8, type 2 diabetic nephropathy
REFERENCES
- 1. Stahl RA, Thaiss F, Disser M, Helmchen U, Hora K, Schlondorff D. 1993. Increased expression of monocyte chemoattractant protein‐1 in anti‐thymocyte antibody‐induced glomerulonephritis. Kidney Int 44:1036–1047. [DOI] [PubMed] [Google Scholar]
- 2. Rovin BH, Doe N, Tan LC. 1996. Monocyte chemoattractant protein‐1 levels in patients with glomerular disease. Am J Kidney Dis 27:640–646. [DOI] [PubMed] [Google Scholar]
- 3. Saitoh A, Suzuki Y, Takeda M, Kubota K, Itoh K, Tomino Y. 1998. Urinary levels of monocyte chemoattractant protein (MCP)‐1 and disease activity in patients with IgA nephropathy. Clin Lab Anal 12:1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Baggiolini M, Dewald B, Moser B. 1994. Interleukin‐8 and related chemotactic cytokines—CXC and CC chemokines. Adv Immunol 55:97–179. [PubMed] [Google Scholar]
- 5. Sica A, Wang JM, Colotta F, et al. 1990. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL‐1 and tumor necrosis factor. J Immunol 144:3034–3038. [PubMed] [Google Scholar]
- 6. Satriano JA, Hora K, Shan Z, Stanley ER, Mori T, Schlondorff D. 1993. Regulation of monocyte chemoattractant protein‐1 and macrophage colony‐stimulating factor‐1 by IFN‐gamma, tumor necrosis factor‐alpha, IgG aggregates, and cAMP in mouse mesangial cells. J Immunol 150:1971–1978. [PubMed] [Google Scholar]
- 7. Yoshimura T, Matsushima K, Tanaka S, et al. 1987. Purification of a human monocyte‐derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci U S A 84:9233–9237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. 1991. Properties of the novel proinflammatory supergene “intercrine” cytokine family. Ann Rev Immunol 9:617–648. [DOI] [PubMed] [Google Scholar]
- 9. Brown Z, Strieter RM, Chensue SW, et al. 1991. Cytokine‐activated human mesangial cells generate the neutrophil chemoattractant, interleukin 8. Kidney Int 40:86–90. [DOI] [PubMed] [Google Scholar]
- 10. Gerritsma JS, Hiemstra PS, Gerritsen AF, et al. 1996. Regulation and production of IL‐8 by human proximal tubular epithelial cells in vitro. Clin Exp Immunol 103:289–294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Young BA, Johnson RJ, Alpers CE, et al. 1995. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47:935–944. [DOI] [PubMed] [Google Scholar]
- 12. Furuta T, Saito T, Ootaka T, et al. 1993. The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 21:480–485. [DOI] [PubMed] [Google Scholar]
- 13. Park IS, Kiyomoto H, Barnes JL, Woodruff K, Abbout HE. 1994. Glomerular monocyte infiltration in early streptozotocin‐induced diabetes is associated with increased expression of transforming growth factor and cellular fibronectin [Abstract]. J Am Soc Nephrol 5:971. [Google Scholar]
- 14. Wada T, Furuichi K, Sakai N, et al. 2000. Up‐regulation of monocyte chemoattractant protein‐1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 58:1492–1499. [DOI] [PubMed] [Google Scholar]
- 15. Ihm CG, Park JK, Hong SP, et al. 1998. A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells. Nephron 79:33–37. [DOI] [PubMed] [Google Scholar]
- 16. Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K. 2000. Possible relationship of monocyte chemoattractant protein‐1 with diabetic nephropathy. Kidney Int 58:684–690. [DOI] [PubMed] [Google Scholar]
- 17. Temaru R, Urakaze M, Satou A, Yamazaki K, Nakamura N, Kobayashi M. 1997. High glucose enhances the gene expression of interleukin‐8 in human endothelial cells, but not in smooth muscle cells: possible role of interleukin‐8 in diabetic macroangiopathy. Diabetologia 40:610–613. [DOI] [PubMed] [Google Scholar]
- 18. Bian ZM, Elner SG, Strieter RM, et al. 1996. Glycated serum albumin induces chemokine gene expression in human retinal pigment epithelial cells. J Leukoc Biol 60:405–414. [DOI] [PubMed] [Google Scholar]
- 19. Ministry of Health and Welfare, Japan . 1990. Research report on diabetes. p 251.
- 20. Yokoyama H, Wada T, Furuichi K, et al. 1998. Urinary levels of chemokines (MCAF/MCP‐1, IL‐8) reflect distinct disease activities and phases of human IgA nephropathy. J Leukoc Biol 63:493–499. [DOI] [PubMed] [Google Scholar]
- 21. Wada T, Yokoyama H, Su SB, et al. 1996. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int 49:761–767. [DOI] [PubMed] [Google Scholar]
- 22. Wada T, Furuichi K, Segawa‐Takaeda C, et al. 1999. MIP‐1alpha and MCP‐1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int 56:995–1003. [DOI] [PubMed] [Google Scholar]
- 23. Wada T, Yokoyama H, Tomosugi N, et al. 1994. Detection of urinary interleukin‐8 in glomerular diseases. Kidney Int 46:455–460. [DOI] [PubMed] [Google Scholar]
- 24. Sekizuka K, Tomino Y, Sei C, et al. 1994. Detection of serum IL‐6 in patients with diabetic nephropathy. Nephron 68:284–285. [DOI] [PubMed] [Google Scholar]